The present data also supports important recent results demonstrating that IL-28B polymorphisms are linked to a better response to antiviral treatment in patients with HCV chronic hepatitis [21][26][27] and to a higher probability of clearing the virus during the natural history of a chronic HCV infection [7][8]. Here, IFNL3 is linked to chronic hepatitis.